GlobalData on MSN8 天
Lundbeck’s amlenetug gains orphan drug status in Japan for MSA
Amlenetug is tailored to attach to all major extracellular α-synuclein forms. The human monoclonal antibody aims to prevent ...
Pharmabiz8 天
Lundbeck’ amlenetug receives Japanese orphan drug designation for treatment of multiple ...
Lundbeck’ amlenetug receives Japanese orphan drug designation for treatment of multiple system atrophy: Denmark Tuesday, March 11, 2025, 11:00 Hrs [IST] H. Lundbeck A/S (Lundbec ...
Morningstar10 天
Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation ...
VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug ...
PharmiWeb10 天
Lundbeck’s potential treatment for Multiple System Atrophy granted Orphan Drug ...
The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple ...
H. Lundbeck A/S: Lundbeck's potential treatment for Multiple System Atrophy granted Orphan ...
The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug ...
Yahoo Finance9 天
Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation ...
VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a ...